The Secretariat of the Southern African Development Community (SADC), the European Union (EU), and the Government of the Federal Republic of Germany have launched a Call for innovative proposals as part of the “COVID-19-relevant Medical and Pharmaceutical Products” (CMPP) Project. It aims at increasing manufacturing capacities for COVID-19-relevant items in the region. This includes, but is not limited to, personal protective equipment, sanitisers and disinfectants, ventilators and related equipment, and pharmaceuticals with increased need in relation to the prevention and treatment of COVID-19. This project is part of the COVID-19 response package developed in emergency by the EU and its Members States – #Team Europe - to support national health systems, protect and save lives and counter the socio-economic impact of the pandemic in the region.
The support is targeted at private and public sector companies and initiatives (e.g. University initiatives, national technology initiatives) in the SADC region. Financial grant will range from EUR 50,000 to EUR 100,000 for for-profit companies, and from EUR 100,000 to EUR 200,000 for non-profit making initiatives, through a joint contribution approach (maximum 75% of the total project costs).
Companies can apply until 24 August 2020. For all details and the eligibility criteria, follow the link: https://www.sadc.int/opportunities/procurement/open-procurement-opportunities/project-production-covid-19-relevant-medical-and-pharmaceutical-products/
The CMPP intervention is a component of the overall programme, “Support towards Industrialization and the Productive Sectors in the SADC region (SIPS).” The SIPS programme is co-funded by the EU and Germany and is being co-implemented by the SADC secretariat and GIZ. The CMPP intervention is managed and implemented by GIZ and is part of the programme “Cooperation for the Enhancement of SADC Regional Economic Integration (CESARE)”.